Ranitidine - Generic Drug Details
✉ Email this page to a colleague
Summary for ranitidine
US Patents: | 0 |
Tradenames: | 9 |
Applicants: | 48 |
NDAs: | 85 |
Drug Master File Entries: | 43 |
Finished Product Suppliers / Packagers: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 51 |
Clinical Trials: | 111 |
Patent Applications: | 5 |
Drug Prices: | Drug price trends for ranitidine |
Drug Sales Revenues: | Drug sales revenues for ranitidine |
What excipients (inactive ingredients) are in ranitidine? | ranitidine excipients list |
DailyMed Link: | ranitidine at DailyMed |
Recent Clinical Trials for ranitidine
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Kasr El Aini Hospital | N/A |
Menoufia University | Phase 2/Phase 3 |
Cairo University | N/A |
Generic filers with tentative approvals for RANITIDINE
Applicant | Application No. | Strength | Dosage Form |
⤷ Sign Up | ⤷ Sign Up | 15MG/ML | Solution; Oral |
The 'tentative' approval signifies that the product meets all FDA standards for marketing, and, but for the patents / regulatory protections, it would approved.